Dyadic International, Inc.
corporate_fare Company Profile
Dyadic International, Inc. (NASDAQ:DYAI) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 31 items for DYAI at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-13, rated 8/10. Across its 20 most recent items scored 7 or higher, the top rating is 9/10, with 14 rated 8 or above. Recent SEC coverage for DYAI spans 10-Q, 8-K, 424B5, DEFA14A.
Recent high-impact activity:
- Dyadic 10-Q: Going Concern Reaffirmed, Cash Funds Operations Only ~7 Months
- Q3 Revenue Drops 61.4% to $449.1K as Dyadic Flags Going-Concern Doubt
- Dyadic Faces Two Nasdaq Delisting Notices Over Bid Price and Market Value Shortfalls
- Dyadic H1 Revenue Up 52% But Losses Widen; $2.9M Share Sale to Fund Operations
- Dyadic Prices $2.9M Registered Direct Offering with Warrants at $0.795/Share
Financial Snapshot
Short Interest & Short Volume
1.00 days to coverFINRA reported short interest of 83,236 shares in DYAI as of the October 30, 2026 settlement, a 57.3% decrease from the prior period — about 1.0 days to cover at its recent average daily volume. On November 20, 2026, 71.0% of DYAI volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.
Dilution Risk
Low riskFiling-implied dilution signals for DYAI, detected from its recent SEC filings · based on capital-structure filings through 2026-08-13.
Registered Direct Offering Priced · Concurrent Warrant Placement
A filing-implied signal, not a realized share count. How Wiseek tracks dilution →